- MyIllumina
- Tools
Illumina's standalone KaryoStudio software package offers functionalities specifically designed for the cytogenetics lab. Developed in collaboration with molecular cytogeneticists, KaryoStudio software provides a user-friendly interface for loading, displaying, and analyzing data using simple, easy-to-use workflows along with cross-matching and reporting functions. This software solution supports analysis of data generated by Illumina's Infinium HD BeadChips including the HumanCytoSNP-12 BeadChip.
| KaryoStudio Highlights | |
|---|---|
| Simplified Analysis | Offers user-friendly, intuitive analysis of Infinium HD BeadChip data |
| Filters | Allows for customization of data and inclusion or exclusion of benign CNVs |
| Automated Detection | Identifies aberrant regions with 0-4 copies including loss of heterozygosity |
| Integrated Chromosomal Browser | Displays gene information, found regions, and regions previously associated with phenotypes |
| Cross-matching | Links to databases such as the Database of Genomic Variants, UCSC genome browser, and DECIPHER for further data analysis |
| Adjustable Database | Enables use of standard region list, or customer-selected regions and phenotypes for cross-matching |
| Reporting | Generates PDF reports summarizing results |
| Comprehensive User Guide | Describes recommended workflows, how to analyze data, and how to generate reports |
System Requirements
8GB RAM on a 64-bit system (recommended)
4GB RAM on a 32-bit system (minimum)
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.